tiprankstipranks
Trending News
More News >
Agilon Health (AGL)
NYSE:AGL
US Market
Advertisement

Agilon Health (AGL) Earnings Dates, Call Summary & Reports

Compare
349 Followers

Earnings Data

Report Date
Mar 03, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.26
Last Year’s EPS
-0.26
Same Quarter Last Year
Based on 15 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of both positive and negative aspects. While agilon Health highlighted operational improvements, cost reductions, and successful clinical programs, significant financial challenges such as negative margins, declining membership, and lower-than-expected risk adjustments were also evident.
Company Guidance
During agilon Health's Third Quarter 2025 Earnings Conference Call, the company provided guidance for fiscal year 2025, expecting revenue to reach $5.82 billion and medical margin to be $5 million, with adjusted EBITDA projected at negative $258 million. These figures incorporate the impact of lower-than-expected risk scores for 2025 and expenses related to exited markets, partially mitigated by positive developments in the first half medical costs and strong performance in ACO REACH. The company highlighted several strategic initiatives, including reducing operating costs by $30 million, enhancing data analytics capabilities, and aligning incentives with payer partners to drive improved financial performance in 2026. They anticipate a 9% benchmark rate increase and more favorable payer contract terms, which will contribute to the expected improvements in medical margin and adjusted EBITDA next year.
Positive Developments for 2026
The company expects 2026 to be a strong stepping stone with enhanced financial data pipeline ramping to 80% in membership and Part D exposure potentially moving below 30%. They foresee improved forecasting, lower volatility, and significant internal and market-driven tailwinds.
Operating Cost Reductions
agilon Health has reduced operating costs by $30 million and expects further savings in 2026 through strategic realignment, centralization of functions, and alignment with PCP partners.
Strong ACO REACH Performance
The ACO REACH program performed ahead of expectations with an adjusted EBITDA of $18 million, demonstrating the value agilon can deliver and shaping the transformation of their MA business.
Enhanced Stars Ratings
Approximately 75% of agilon members are expected to be in 4+ Star plans in 2027, an increase from 71% in the 2026 payment year, which supports better payer economics.
Clinical Program Success
The heart failure pathway reduced new inpatient heart failure diagnosis rates from 18% in 2024 to 5% in 2025. Virtual pharmacy solutions led to 30-day readmission rates falling below 5% compared to the national average of 20%.

Agilon Health (AGL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AGL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 03, 2026
2025 (Q4)
-0.26 / -
-0.26
Nov 04, 2025
2025 (Q3)
-0.15 / -0.27
-0.296.90% (+0.02)
Aug 07, 2025
2025 (Q2)
-0.11 / -0.25
-0.07-257.14% (-0.18)
May 06, 2025
2025 (Q1)
>-0.01 / 0.03
0.01190.00% (+0.02)
Feb 25, 2025
2024 (Q4)
-0.22 / -0.26
-0.4136.59% (+0.15)
Nov 07, 2024
2024 (Q3)
-0.10 / -0.29
-0.08-262.50% (-0.21)
Aug 06, 2024
2024 (Q2)
-0.07 / -0.07
-0.04-75.00% (-0.03)
May 07, 2024
2024 (Q1)
-0.01 / 0.01
0.04-75.00% (-0.03)
Feb 27, 2024
2023 (Q4)
-0.28 / -0.41
-0.14-192.86% (-0.27)
Nov 02, 2023
2023 (Q3)
-0.05 / -0.08
-0.07-14.29% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AGL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$0.72$0.75+4.01%
Aug 07, 2025
$0.88$0.87-0.23%
May 06, 2025
$4.46$3.39-23.99%
Feb 25, 2025
$3.63$3.36-7.44%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Agilon Health (AGL) report earnings?
Agilon Health (AGL) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
    What is Agilon Health (AGL) earnings time?
    Agilon Health (AGL) earnings time is at Mar 03, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AGL EPS forecast?
          AGL EPS forecast for the fiscal quarter 2025 (Q4) is -0.26.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis